SEARCH

SEARCH BY CITATION

References

  • Alderman , C. P. , C. K. Moritz & D. L. Ben-Tovim : Abnormal platelet aggregation associated with fluoxetine therapy. Ann. Pharmacother. 1992, 26, 15171519.
  • Berk , M. , B. F. Jacobson & E. Hurly : Fluoxetine and hemostatic function: a pilot study. J. Clin. Psychiatry. 1995, 56, 1416.
  • Calhoun , J. W. & D. D. Calhoun : Prolonged bleeding time in a patient treated with sertraline. Amer. J. Psychiatry 1996, 153, 443.
  • Cheeta , S. , F. Schifano , A. Oyfeso , L. Webb & A. H. Ghodse : Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000. Brit. J. Psychiatry 2004, 184, 4147.
  • Dalton , S. O. , C. Johansen , L. Mellemkjær , B. Nørgård , H. T. Sørensen & J. H. Olsen : Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding – a population-based cohort study. Arch. Intern. Med. 2003, 165, 5964.
  • De Abajo , F. J. , L. A. García Rodríguez & D. Montero : Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Brit. Med. J. 1999, 319, 11061109.
  • De Abajo , F. J. , H. Jick , L. Derby , S. Jick & S. Schmitz : Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Brit. J. Clin. Pharmacol. 2000, 50, 4347.
  • Dunn , N. R. , G. L. Pearce & S. A. W. Shakir : SSRIs are not more likely than other drugs to cause such bleeding. Brit. Med. J. 2000, 320, 1405 (Letter to the Editor ).
  • García-Rodríguez , L. A. & S. Pérez Gutthann : Use of the UK General Practice Research Database for pharmacoepidemiology. Brit. J. Clin. Pharmacol. 1998, 45, 419425.
  • Gunnell , D. & D. Ashby : Antidepressants and suicide: what is the balance of benefit and harm. Brit. Med. J. 2004, 329, 3438.
  • Hergovich , N. , M. Aigner , H. G. Eichler , J. Entlicher , C. Drucker & B. Jilma : Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin. Pharmacol. Therap. 2000, 68, 435442.
  • Hernández-Díaz , S. & L. A. García-Rodríguez : Overview of epidemiological studies Publisher in the nineties on the association between non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding/perforation. Arch. Intern. Med. 2000, 160, 20932099.
  • Humphries , J. E. , M. S. Wheby & S. R. VandenBerg : Fluoxetine and the bleeding time. Arch. Pathol. Lab. Med. 1990, 114, 727728.
  • Ishikawa , K. , S. Shibanoki , T. Kubo , S. Watabe , A. Matsumoto & M. Kogure : Effects of various tricyclic antidepressants on amine uptake. Eur. J. Pharmacol. 1986, 120, 6368.
  • Javors , M. A. , J. P. Houston , J. L. Tekell , S. K. Brannan & A. Frazer : Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int. J. Neuropsychopharmacol. 2000, 3, 229235.
  • Jureidini , J. N. , C. Doecke , P. R. Mansfield , M. M. Haby , D. B. Menkes & A. L. Tonkin : Efficacy and safety of antidepressants for children and adolescents. Brit. Med. J. 2004, 328, 879883.
  • Khon , S. & L. A. Labbate : Venlafaxine and ecchymosis. Can. J. Psychiatry 1997, 42, 91.
  • Layton , D. , D. W. J. Clark , G. L. Pearce & S. A. W. Shakir : Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur. J. Clin. Pharmacol. 2001, 57, 167176.
  • Lesch , K. P. , B. L. Wolozin , D. L. Murphy & R. Reiderer : Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 1993, 60, 23192322.
  • Leung , M. & R. Shore : Fluvoxamine-associated bleeding. Can. J. Psychiatry 1996, 41, 604605.
  • Lingjærde , O. : Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants. Pharmacology & Toxicology 1990, 66 (Suppl. 3), 6168.
  • Markovitz , J. H. , S. L. Shuster , W. S. Chitwood , R. S. May & L. C. Tolbert : Platelet activation in depression and effects of sertraline treatment: an open-label study. Amer. J. Psychiatry 2000, 157, 1006.
  • Martesson , B. , A. Wagner , O. Beck , K. Brodin , D. Montero & M. Asberg : Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta psychiat. scand. 1991, 83, 125133.
  • Martinez , C. , S. Rietbrock , L. Wise , D. Ashby , J. Chick , J. Moseley , S. Evans & D. Gunnell : Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. Brit. Med. J. 2005, 330, 389.
  • Maurer-Spurej , E. : Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell. Mol. Life Sci. 2005, 62, 159170.
  • Meijer , W. E. E. , E. R. Heerdink , W. A. Nolen , R. M. C. Herings , H. G. M. Leufkens & A. C. G. Egberts : Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch. Inter. Med. 2004, 164, 23672370.
  • Montero , D. , R. Coulson , F. J. De Abajo , G. Martín-Serrano , M. Prieto & N. Moore : Selective serotonin reuptake inhibitors and bleeding disorders. Fourth annual meeting of the European Society of Pharmacovigilance. Lisbon, 1996.
  • Movig , K. L. L. , M. W. H. E. Janssen , J. W. Malefijt , P. J. Kabel , H. G. M. Leufkens & A. C. G. Egberts : Relationship of serotoninergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch. Intern. Med. 2003, 163, 23542358.
  • Mück-Seler , D. , M. Jakovjevic & Z. Deanovic : Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients. J. Affect. Dis. 1991, 23, 157164.
  • Narayan , M. , G. Anderson , J. Cellar , R. T. Mallison , L. H. Price & J. C. Nelson : Serotonin trnasporter-blocking properties of nefazodone assessed by measurement of platelet serontonin. J. Clin. Psychopharmacol. 1998, 18, 6771.
  • Ottervanger , J. P. , B. H. C. H. Stricker , J. Huls & J. N. Weeda : Bleeding attributed to the intake of paroxetine. Amer. J. Psychiatry 1994, 151, 781.
  • Owens , M. J. : Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. J. Clin. Psychiatry 2004, 65, 510.
  • Pigott , T. A. , F. L'Hereux , C. S. Rubestein , S. E. Berstein , J. L. Hill & D. L. Murphy : A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. J. Clin. Psychopharmacol. 1992, 12, 156162.
  • Sanz , E. J. , C. De Las Cuevas , A. Kiuru , A. Bate & R. Edwards : Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005, 365, 482487.
  • Serebruany , V. L. , P. A. Gurbel & C. M. O'Connor : Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol. Res. 2001, 43, 453462.
  • Skop , B. P. & T. M. Brown : Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996, 37, 1216.
  • Tata , L. J. , P. J. Fortun , R. B. Hubbard , L. Smeeth , C. J. Hawkey , C. J. P. Smith , H. J. Whitaker , C. P. Farrington , T. R. Card & J. West : Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment. Pharmacol. Therap. 2005, 22, 175181.
  • Tatsumi , M. , K. Groshan , R. D. Blakely & E. Richelson : Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 1997, 340, 249258.
  • Uppsala Monitoring Centre. Viewpoint Part 2. UMC: Uppsala, 2005, pag 15 Available on website: http:(www.who-umc.org).
  • Van Walraven , C. , M. M. Mamdami , P. S. Wells & J. I. Williams : Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. Brit. Med. J. 2001, 323, 16.
  • Wagner , A. , D. Montero , B. Martensson , B. Siwers & M. Asberg : Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J. Affect. Dis. 1990, 20, 101113.
  • Wessinger , S. , M. Williams , L. Choi , L. K. Sharp , M. D. Crowell , A. Keshavarzian & M. P. Jones : Increased use of selective serotonin reuptake inhibitors in patients admitted with acute gastrointestinal hemorrhage: preliminary observations. Digestive Diseases Week Conference, Chicago, 2005.
  • Yaryura-Tobias , J. A. , H. Kirschen , P. Ninan & H. J. Mosberg : Fluoxetine and bleeding in obsessive-compulsive disorder. Amer. J. Psychiatry 1991, 148, 949.